Ona Therapeutics was created in 2019 and is specialised in the discovery and development of therapeutic biologics targeting tumour metastatic-initiating cells and lipid metabolism. This therapeutic approach has the potential to prevent the formation of metastases and eliminate existing ones in multiple types of cancer.In 2020, Ona Therapeutics closed a large series A 30M investment round with an international expert syndicate of VCs.
